BOULDER, Colo., Dec. 4, 2012 /PRNewswire/ -- Sophono, Inc., has named Richard Giancola vice president – global sales and marketing.
(Photo: http://photos.prnewswire.com/prnh/20121204/PH23027 )
The medical device manufacturer, specializing in implantable, bone conduction hearing devices, makes the appointment as it continues its rapid-growth pace. The company recently introduced its second-generation Alpha 2 hearing device for individuals suffering from severe to profound hearing loss or impairment. The FDA-cleared Sophono Alpha is the only abutment-free, implantable, bone-anchored hearing device on the market today, eliminating the problematic abutment of devices by using magnets to affix external sound processors.
Giancola previously served as CEO of Neuromonics, Inc., a medical device manufacturer of products and services to treat tinnitus. Before that time, he held the positions of vice president for Latin America and Canadian business at Cochlear Americas (Centennial, Colo.), and vice president and general manager for Latin America.
Giancola has worked in sales and marketing for Spectramed Corporation, Deseret Medical and Far Western Hospital Supply, and custom products manager for American Hospital Supply, all in Denver. He also was founder and president of Landmark Medical Exports, Inc. (Denver), an export management and consulting company.
The vice president holds a Bachelor of Arts degree from Hobart College (Geneva, N.Y.) and Master of Business Administration degree from Syracuse University. In the community, Giancola is a co-chair of the Colorado host committee for the 2014 men's world lacrosse championships. He is active with the Colorado Lacrosse Foundation, chairs the organization's Hall of Fame committee, and is a past president.
Sophono, Inc., is a medical device manufacturer specializing in implantable, bone conduction hearing devices. The company's products are designed for individuals suffering from severe to profound hearing loss or impairment. The Sophono Alpha is the only abutment-free, implantable, bone-anchored hearing device. Treating those with conductive hearing loss, mixed hearing loss, and single-ear deafness, the FDA-cleared product Alpha eliminates the problematic abutment of devices by using magnets to affix external sound processors.
Sophono corporate headquarters and manufacturing operations reside in Boulder, Colo. The company maintains an office in Germany, works with more than 20 distributors, and is actively selling in more than 30 countries.
Contacts: Jeff Rona, Sophono, 720-432-4070, firstname.lastname@example.org
Aimee Bennett, Fagan Business Communications, 303-843-9840, email@example.com
This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.
SOURCE Sophono, Inc